Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

NYSE American · Common stock

Lineage Cell Therapeutics (LCTX)

$0.9969 $0.00 (−0.31%)

Day’s range
$0.9616–$1.01
Volume
1.9M

LCTX price history

LCTX closed at $0.9969 on Oct. 26, 2026. Over the past year, its daily close ranged from $0.9042 on Oct. 1, 2026 to $1.96 on Nov. 3, 2025.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $0.5000 to $2.00, not from zero.
Data table: LCTX daily closes, the past year
LCTX daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$0.9969
Oct. 23, 2026$1.00
Oct. 22, 2026$0.9850
Oct. 21, 2026$0.9515
Oct. 20, 2026$0.9726
Oct. 19, 2026$0.9528
Oct. 16, 2026$0.9783
Oct. 15, 2026$0.9903
Oct. 14, 2026$0.9175
Oct. 13, 2026$0.9083
Oct. 12, 2026$0.9541
Oct. 9, 2026$0.9940
Oct. 8, 2026$1.03
Oct. 7, 2026$0.9476
Oct. 6, 2026$0.9379
Oct. 5, 2026$0.9274
Oct. 2, 2026$0.9303
Oct. 1, 2026$0.9042
Sept. 30, 2026$0.9557
Sept. 29, 2026$0.9475
Sept. 28, 2026$0.9710
Sept. 25, 2026$1.03
Sept. 24, 2026$0.9478
Sept. 23, 2026$0.9567
Sept. 22, 2026$1.04
Sept. 21, 2026$1.01
Sept. 18, 2026$1.03
Sept. 17, 2026$1.03
Sept. 16, 2026$1.07
Sept. 15, 2026$1.06
Sept. 14, 2026$1.07
Sept. 11, 2026$1.01
Sept. 10, 2026$1.02
Sept. 9, 2026$1.03
Sept. 8, 2026$1.09
Sept. 4, 2026$1.08
Sept. 3, 2026$1.10
Sept. 2, 2026$1.11
Sept. 1, 2026$1.08
Aug. 31, 2026$1.10
Aug. 28, 2026$1.11
Aug. 27, 2026$1.16
Aug. 26, 2026$1.12
Aug. 25, 2026$1.13
Aug. 24, 2026$1.09
Aug. 21, 2026$1.08
Aug. 20, 2026$1.08
Aug. 19, 2026$1.10
Aug. 18, 2026$1.06
Aug. 17, 2026$1.06
Aug. 14, 2026$1.07
Aug. 13, 2026$1.06
Aug. 12, 2026$1.10
Aug. 11, 2026$1.12
Aug. 10, 2026$1.13
Aug. 7, 2026$1.10
Aug. 6, 2026$1.13
Aug. 5, 2026$1.14
Aug. 4, 2026$1.12
Aug. 3, 2026$1.11
July 31, 2026$1.08
July 30, 2026$1.11
July 29, 2026$1.06
July 28, 2026$1.07
July 27, 2026$1.03
July 24, 2026$1.03
July 23, 2026$1.07
July 22, 2026$1.11
July 21, 2026$1.14
July 20, 2026$1.10
July 17, 2026$1.16
July 16, 2026$1.17
July 15, 2026$1.22
July 14, 2026$1.22
July 13, 2026$1.21
July 10, 2026$1.28
July 9, 2026$1.29
July 8, 2026$1.34
July 7, 2026$1.32
July 6, 2026$1.33
July 2, 2026$1.35
July 1, 2026$1.30
June 30, 2026$1.31
June 29, 2026$1.35
June 26, 2026$1.28
June 25, 2026$1.22
June 24, 2026$1.26
June 23, 2026$1.25
June 22, 2026$1.26
June 18, 2026$1.21
June 17, 2026$1.25
June 16, 2026$1.20
June 15, 2026$1.23
June 12, 2026$1.27
June 11, 2026$1.28
June 10, 2026$1.23
June 9, 2026$1.22
June 8, 2026$1.21
June 5, 2026$1.19
June 4, 2026$1.21
June 3, 2026$1.20
June 2, 2026$1.21
June 1, 2026$1.26
May 29, 2026$1.33
May 28, 2026$1.33
May 27, 2026$1.30
May 26, 2026$1.29
May 22, 2026$1.30
May 21, 2026$1.32
May 20, 2026$1.29
May 19, 2026$1.20
May 18, 2026$1.24
May 15, 2026$1.25
May 14, 2026$1.31
May 13, 2026$1.28
May 12, 2026$1.33
May 11, 2026$1.31
May 8, 2026$1.37
May 7, 2026$1.37
May 6, 2026$1.43
May 5, 2026$1.46
May 4, 2026$1.42
May 1, 2026$1.53
April 30, 2026$1.51
April 29, 2026$1.46
April 28, 2026$1.56
April 27, 2026$1.55
April 24, 2026$1.55
April 23, 2026$1.56
April 22, 2026$1.63
April 21, 2026$1.64
April 20, 2026$1.65
April 17, 2026$1.71
April 16, 2026$1.64
April 15, 2026$1.63
April 14, 2026$1.59
April 13, 2026$1.51
April 10, 2026$1.48
April 9, 2026$1.49
April 8, 2026$1.54
April 7, 2026$1.52
April 6, 2026$1.54
April 2, 2026$1.57
April 1, 2026$1.59
March 31, 2026$1.58
March 30, 2026$1.47
March 27, 2026$1.49
March 26, 2026$1.53
March 25, 2026$1.55
March 24, 2026$1.48
March 23, 2026$1.47
March 20, 2026$1.45
March 19, 2026$1.55
March 18, 2026$1.50
March 17, 2026$1.58
March 16, 2026$1.60
March 13, 2026$1.61
March 12, 2026$1.58
March 11, 2026$1.68
March 10, 2026$1.81
March 9, 2026$1.77
March 6, 2026$1.85
March 5, 2026$1.84
March 4, 2026$1.95
March 3, 2026$1.89
March 2, 2026$1.95
Feb. 27, 2026$1.92
Feb. 26, 2026$1.96
Feb. 25, 2026$1.90
Feb. 24, 2026$1.82
Feb. 23, 2026$1.77
Feb. 20, 2026$1.81
Feb. 19, 2026$1.78
Feb. 18, 2026$1.72
Feb. 17, 2026$1.68
Feb. 13, 2026$1.66
Feb. 12, 2026$1.70
Feb. 11, 2026$1.80
Feb. 10, 2026$1.84
Feb. 9, 2026$1.67
Feb. 6, 2026$1.70
Feb. 5, 2026$1.68
Feb. 4, 2026$1.74
Feb. 3, 2026$1.76
Feb. 2, 2026$1.54
Jan. 30, 2026$1.48
Jan. 29, 2026$1.57
Jan. 28, 2026$1.58
Jan. 27, 2026$1.63
Jan. 26, 2026$1.59
Jan. 23, 2026$1.61
Jan. 22, 2026$1.65
Jan. 21, 2026$1.66
Jan. 20, 2026$1.65
Jan. 16, 2026$1.70
Jan. 15, 2026$1.65
Jan. 14, 2026$1.70
Jan. 13, 2026$1.67
Jan. 12, 2026$1.76
Jan. 9, 2026$1.71
Jan. 8, 2026$1.76
Jan. 7, 2026$1.83
Jan. 6, 2026$1.70
Jan. 5, 2026$1.69
Jan. 2, 2026$1.64
Dec. 31, 2025$1.67
Dec. 30, 2025$1.60
Dec. 29, 2025$1.63
Dec. 26, 2025$1.65
Dec. 24, 2025$1.68
Dec. 23, 2025$1.66
Dec. 22, 2025$1.73
Dec. 19, 2025$1.68
Dec. 18, 2025$1.75
Dec. 17, 2025$1.77
Dec. 16, 2025$1.80
Dec. 15, 2025$1.72
Dec. 12, 2025$1.66
Dec. 11, 2025$1.71
Dec. 10, 2025$1.74
Dec. 9, 2025$1.74
Dec. 8, 2025$1.69
Dec. 5, 2025$1.72
Dec. 4, 2025$1.74
Dec. 3, 2025$1.68
Dec. 2, 2025$1.61
Dec. 1, 2025$1.66
Nov. 28, 2025$1.76
Nov. 26, 2025$1.71
Nov. 25, 2025$1.74
Nov. 24, 2025$1.75
Nov. 21, 2025$1.74
Nov. 20, 2025$1.67
Nov. 19, 2025$1.71
Nov. 18, 2025$1.77
Nov. 17, 2025$1.74
Nov. 14, 2025$1.88
Nov. 13, 2025$1.80
Nov. 12, 2025$1.93
Nov. 11, 2025$1.82
Nov. 10, 2025$1.81
Nov. 7, 2025$1.76
Nov. 6, 2025$1.73
Nov. 5, 2025$1.82
Nov. 4, 2025$1.80
Nov. 3, 2025$1.96
Oct. 31, 2025$1.92
Oct. 30, 2025$1.84
Oct. 29, 2025$1.71
Oct. 28, 2025$1.73
Oct. 27, 2025$1.75

Key figures

52-week range
$0.9042–$1.96Low Oct. 1, 2026; high Feb. 26, 2026
Average daily volume
1.3MPast 3 months
Market value
$252.1M
Dividend yield
—
From 52-week high
−49.14%

Price change

1 month
−3.21%
3 months
−3.21%
Year to date
−40.31%
1 year
−41.36%

$1,000 a year ago

$1,000 put into LCTX at the close on Oct. 24, 2025 would be worth $586.

Price only, dividends not included.

What Wall Street says about LCTX

No Wall Street firm has published a rating or price-target change on LCTX in the past 90 days.

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Headquarters
Carlsbad, Calif.
Employees
77
Listed
March 5, 1992
Sector
Health care
Industry
Biological products, (no diagnostic substances)

lineagecell.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about LCTX is on the site yet.

  • AMGNAmgen Inc
  • GILDGilead Sciences Inc
  • MRNAModerna, Inc. Common Stock
  • RVMDRevolution Medicines, Inc. Common Stock
  • BIIBBiogen Inc. Common Stock
  • EXELExelixis Inc